1 Aslam B, Wang W, Arshad MI, et al. Antibiotic resistance: a rundown of a global crisis. Infect Drug Resist. 2018;11:1645–58.
2 Morehead MS, Scarbrough C. Emergence of Global Antibiotic Resistance. Prim Care. 2018;45(3):467–84.
3 Singu S, Acharya A, Challagundla K, Byrareddy SN. Impact of Social Determinants of Health on the Emerging COVID-19 Pandemic in the United States. Front Public Health. 2020;8:406.
4 Deeks JJ, Dinnes J, Takwoingi Y, et al. Antibody tests for identification of current and past infection with SARS-CoV-2. Cochrane Database Syst Rev.2020;6:CD013652.
5 Dinnes J, Deeks JJ, Adriano A, et al. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection. Cochrane Database Syst Rev. 2020;8:CD013705.
6 Dodig S, Cepelak I, Cepelak Dodig D, Laskaj R. SARS-CoV-2 – a new challenge for laboratory medicine. Biochem Med (Zagreb). 2020;30(3):030503.
7 Goldenberger D, Leuzinger K, Sogaard KK, et al. Brief validation of the novel GeneXpert Xpress SARS-CoV-2 PCR assay. J Virol Methods. 2020;284:113925.
8 Leuzinger K, Roloff T, Gosert R, et al. Epidemiology of SARS-CoV-2 Emergence Amidst Community-Acquired Respiratory Viruses. J Infect Dis. 2020.
9 Wassilew N, Seth-Smith HM, Rolli E, et al. Outbreak of vancomycin-resistant Enterococcus faecium clone ST796, Switzerland, December 2017 to April 2018. Euro Surveill. 2018;23(29).
10 Liu YY, Wang Y, Walsh TR, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis. 2016;16(2):161–8.
11. Kumarasamy KK, Toleman MA, Walsh TR, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis. 2010;10(9):597–602.
12 Poirel L, Schrenzel J, Cherkaoui A, Bernabeu S, Renzi G, Nordmann P. Molecular analysis of NDM-1-producing enterobacterial isolates from Geneva, Switzerland. J Antimicrob Chemother. 2011;66(8):1730–3.
13 Ramette A, Gasser M, Nordmann P, Zbinden R, Schrenzel J, Perisa D, Kronenberg. A Temporal and regional incidence of carbapenemase-producing Enterobacterales in Switzerland from 2013 to 2018. Accepted in Eurosurveillance.
14 Bleichenbacher S, Stevens MJA, Zurfluh K, et al. Environmental dissemination of carbapenemase-producing Enterobacteriaceae in rivers in Switzerland. Environ Pollut. 2020; 65(Pt B):115081.
15 Hernando-Amado S, Coque TM, Baquero F, Martinez JL. Defining and combating antibiotic resistance from One Health and Global Health perspectives. Nat Microbiol. 2019;4(9):1432–42.
16 Morens DM, Fauci AS. Emerging Pandemic Diseases: How We Got to COVID-19. Cell 2020.
17 Cassini A, Hogberg LD, Plachouras D, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019;19(1):56–66.
18 Getahun H, Smith I, Trivedi K, Paulin S, Balkhy HH. Tackling antimicrobial resistance in the COVID-19 pandemic. Bull World Health Organ. 2020;98(7):442-A.
19 Tiri B, Sensi E, Marsiliani V, et al. Antimicrobial Stewardship Program, COVID-19, and Infection Control: Spread of Carbapenem-Resistant Klebsiella Pneumoniae Colonization in ICU COVID-19 Patients. What Did Not Work? J Clin Med. 2020;9(9).
20 Vaillancourt M, Jorth P. The Unrecognized Threat of Secondary Bacterial Infections with COVID-19. mBio. 2020;11(4).
21 Wise R. Antimicrobial resistance: priorities for action. The Journal of antimicrobial chemotherapy. 2002;49(4):585–6.
22 Combating Antimicrobial Resistance: A One Health Approach to a Global Threat: Proceedings of a Workshop. Washington (DC); 2017.
23 Hoffman SJ, Caleo GM, Daulaire N, et al. Strategies for achieving global collective action on antimicrobial resistance. Bull World Health Organ. 2015;93(12):867–76.
24 Organisation WH. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. 2017. https://www.who.int/medicines/publications/global-priority-list-antibiotic-resistant-bacteria/en/ (accessed 31.08.2020 2020).
25 J ON. Tackling Drug-Resistant Infections Globally: Final Report and Recommendations, 2016.
26 Gasser M, Zingg W, Cassini A, Kronenberg A, Swiss Centre for Antibiotic R. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in Switzerland. Lancet Infect Dis. 2019;19(1):17–8.
27 Babouee B, Widmer AF, Dubuis O, et al. Emergence of four cases of KPC-2 and KPC-3-carrying Klebsiella pneumoniae introduced to Switzerland, 2009-10. Euro surveillance: bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin. 2011;16(11).
28 Ruppe E, Olearo F, Pires D, et al. Clonal or not clonal? Investigating hospital outbreaks of KPC-producing Klebsiella pneumoniae with whole-genome sequencing. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2017;23(7):470–5.
29 Canton R, Akova M, Carmeli Y, et al. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2012;18(5):413–31.
30 Buetti N, Wassilew N, Rion V, et al. Emergence of vancomycin-resistant enterococci in Switzerland: a nation-wide survey. Antimicrob Resist Infect Control. 2019;8:16.
31 Olearo F, Albrich WC, Vernaz N, Harbarth S, Kronenberg A, Swiss Centre For Antibiotic Resistance A. Staphylococcus aureus and methicillin resistance in Switzerland: regional differences and trends from 2004 to 2014. Swiss Med Wkly. 2016;146:w14339.
32 Meinel DM, Kuehl R, Zbinden R, et al. Outbreak investigation for toxigenic Corynebacterium diphtheriae wound infections in refugees from Northeast Africa and Syria in Switzerland and Germany by whole genome sequencing. Clin Microbiol Infect. 2016; 22(12):1003 e1–e8.
33 Piso RJ, Kach R, Pop R, et al. A Cross-Sectional Study of Colonization Rates with Methicillin-Resistant Staphylococcus aureus (MRSA) and Extended-Spectrum Beta-Lactamase (ESBL) and Carbapenemase-Producing Enterobacteriaceae in Four Swiss Refugee Centres. PLoS One. 2017; 12(1):e0170251.
34 Meinel D, Egli A. Next Generation Sequencing. Swiss Medical Forum. 2017;17(0102):16–8.
35 Zankari E. Comparison of the web tools ARG-ANNOT and ResFinder for detection of resistance genes in bacteria. Antimicrobial agents and chemotherapy. 2014;58(8):4986.
36 Jia B, Raphenya AR, Alcock B, et al. CARD 2017: expansion and model-centric curation of the comprehensive antibiotic resistance database. Nucleic acids research. 2017;45(D1):D566–D73.
37 Meinel D, Seth-Smith H, Egli A. Whole Genome Sequencing. Swiss Medical Forum. 2017;17(1516):348–55.
38 Egli A, Blanc DS, Greub G, et al. Improving the quality and workflow of bacterial genome sequencing and analysis: paving the way for a Switzerland-wide molecular epidemiological surveillance platform. Swiss Med Wkly. 2018;148:w14693.
39 Budd J, Miller BS, Manning EM, et al. Digital technologies in the public-health response to COVID-19. Nat Med 2020;26(8):1183–92.